investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Preclinical Drug Development in Pancreatic Cancer

Udo Rudloff

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Duncan Jodrell

University of Cambridge

Cambridge, United Kingdom

Cancer Research UK (CRUK)

London, United Kingdom

Udo Rudloff

National Cancer Institute (NIH)

Rockville, United States

Related projects

Peng Wei

Genetic Susceptibility and Risk Model for Pancreatic Cancer

Pancreas

Pathology

Anthony G Letai

Investigation of therapeutic modulators of apoptotic priming in pancreatic cancer

Pancreas

Pathology

Keping Xie

Molecular Mediators of Pancreatic Cancer Invasion and Progression

Pancreas

Pathology

Channing J Der

Biological Activity of Ras Oncogenes

Pancreas

Pathology

Kenneth W Gross

(Epi)Genomic Drivers of Primary and Metastatic Pancreatic Islet Cell Carcinoma

Pancreas

Pathology

S Perwez Hussain

Role of Immune and Inflammation Mediators in Progression of Pancreatic Cancer

Pancreas

Pathology

Denis C Guttridge

(PQD6) Muscle Stem Cells and Cancer Cachexia

Pancreas

Pathology

Philip D Greenberg

Mechanisms of Murine Turmor Eradication by Immunotherapy

Pancreas

Pathology

Jacob Houghton

Developing an Anti-sialyl-Lewisa Diabody for ImmunoPET Imaging of Pancreas Cancer

Pancreas

Pathology